The Globe and Mail reports in its Friday, Jan. 24, edition that Canaccord Genuity analyst Yuri Lynk has reaffirmed his "buy" recommendation for Atkinsrealis Group. The Globe's David Leeder writes in the Eye On Equities column that Mr. Lynk saw his share target soar $20 to $100. Analysts on average target the shares at $84.42. Mr. Lynk says in a note: "We are moving to an EV/EBITDA methodology to value PS&PM to better compare Atkinsrealis Group to its engineering services and nuclear peers, which largely do not trade on P/E. Taking into account that nuclear comparables BWX Technologies, Curtiss-Wright, and Mirion Technologies trade at an average of 21 times EV/EBITDA (2025E), we are setting our blended target multiple at 15 times. Our prior target equated to a 12 times multiple, which appears increasingly conservative given that engineering services peers such as AECOM, Jacobs, Stantec, Tetra Tech, and WSP Global trade at an average of 16 times EV/EBITDA (2025E)." The Globe reported on Dec. 13 that CIBC World Markets analyst Krista Friesen continued to rate Atkinsrealis Group "outperformer." The shares could then be had for $74.76.